Add Company
Join Now

Context Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Context Therapeutics's estimated annual revenue is currently $2M per year.(i)
  • Context Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Context Therapeutics has 13 Employees.(i)
  • Context Therapeutics grew their employee count by -19% last year.

Context Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Chief Legal OfficerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
SVP OperationsReveal Email/Phone
5
Senior Director QualityReveal Email/Phone
6
Program Management Consultant at Context TherapeuticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Context Therapeutics?

Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating new medicines to treat female hormone-dependent cancers. Context’s lead program is onapristone extended release (ONA-XR), an investigational Phase 2 drug that is being developed for progesterone receptor positive (PR+) breast, endometrial, and ovarian cancers.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M130%N/A
#2
$1.1M130%N/A
#3
$7.5M13-7%N/A
#4
$7.5M13-24%N/A
#5
$2M130%N/A